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Nanoparticles (NPs) typically accumulate in lysosomes. However, their
impact on lysosomal function, as well as autophagy, a lysosomal degradative
pathway, is still not well known. We have previously reported in the 1321N1
cell line that amine-modified polystyrene (NH2-PS) NPs induce apoptosis
through damage initiated in the lysosomes leading ultimately to release of
lysosomal content in the cytosol, followed by apoptosis. Here, by using a com-
bination of biochemical and cell biological approaches, we have characterized
in amouse embryonic fibroblast cell line that the lysosomal alterations induced
by NH2-PS NPs is progressive, initiating frommild lysosomal membrane per-
meabilization (LMP), to expansion of lysosomal volume and intensive LMP
before the summit of cell death. Though the cells initially seem to induce
autophagy as a surviving mechanism, the damage of NH2-PS NPs to lyso-
somes probably results in lysosomal dysfunctions, leading to blockage of
autophagic flux at the level of lysosomes and the eventual cell death.1. Introduction
Damage to lysosomes has recently been proposed as an emerging mechanism of
nanotoxicity [1,2], as most endocytosed nanoparticles (NPs) accumulate within
the lysosomal compartments without evident exit [3–5]. Evaluating lysosomal
function after NP accumulation in the lysosomes is important to analyse the toxi-
cological consequences of NPs [2,6]. The so-called ‘protein corona’, namely layers
of proteins and other biomolecules (adsorbed from the cell medium) on the sur-
face of NPs [7,8], also needs to be consideredwhen examining nanotoxicity [9,10].
The composition of the corona is highly dependent on the properties of NPs and
media. When exposed to NPs, the cells ‘see’ the NP/corona complexes, but not
the pristine NPs per se [11,12]. Using amine-modified polystyrene (NH2-PS)
NPs as an example, we have previously shown that the NP/corona complexes
enter cells together and home in lysosomes [9,13]. Once inside lysosomes, the
corona gets degraded by lysosomal enzymes. The degradation of the original
corona layer is accompanied by strong lysosomal alterations [9,14,15]. Although
several reports have proposed the so-called ‘proton sponge’ effect as the mechan-
ism of lysosomal damage by nanomaterials [16,17], similar effects have been
reported also for materials not capable of buffering the lysosomal pH [9,18].
Other mechanisms have also been proposed, involving for instance damage to
chloride channels [19].
Lysosomal alterations are tightly relatedwith lysosomal dysfunction and have
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upon lysosomal membrane permeabilization (LMP), resulting
in the release of lysosomal contents, including proteolytic
enzymes of the cathepsin family, to the cytoplasm [20,22].
Moreover, lysosomal alterations can be associated with dereg-
ulation of autophagy in cell death and diseases [20,23,24].
Autophagy is a self-digestive process dependent on lysoso-
mal degradation, and it is classified as macroautophagy,
chaperone-mediated autophagy and microautophagy. In
macroautophagy (hereafter referred to as autophagy), a
double membrane structure is generated to engulf some cyto-
solic components (such as damaged proteins and organelles)
to form autophagosomes. The resulting autophagosomes
further fuse with lysosomes to form autolysosomes, in which
lysosomal proteases could degrade the engulfed components
inside autophagolysosomes [25,26]. Therefore, when lyso-
somes suffer dysfunction, fusion between autophagosomes
and lysosomes and/or degradation of autophagosomes is
compromised, affecting autophagy.
Thewidely usedmethod to analyse autophagy is the detec-
tion of the lipidated form of themicrotubule-associated protein
1 light chain 3, or LC3-II, as it is recruited to the membrane
of autophagosomes. The amount of LC3-II is relative to the
amount of autophagosomes [27]. However, both induction
and blockage of autophagy could result in the increase of
LC3-II level [27,28]. The more precise autophagy analysis
is therefore to measure autophagic flux (or the rate of
autophagy), in which the turnover of LC3-II is analysed in
the presence and absence of lysosomal inhibitors, such as
chloroquine, bafilomycin A and protease inhibitors [27,29].
A number of NPs have been reported to either activate or
block autophagy, as is summarized in the review of Stern et al.
[2,30]. The autophagy modulating property of NPs can, on the
one hand, be employed for drug targeting purposes [1,31],
while on the other hand, it has been suggested as a toxicity
mechanism of NPs [2]. Nevertheless, very often the possibility
of autophagy blockage induced by NPs was overlooked, as
most detection of autophagy was done by measurement of
LC3-II level alone, as is also mentioned in the review of Stern
et al. [2]. Moreover, in order to be able to determine the flux,
this kind of assay should be done over time, rather than just at
a single time point with different NP doses [32].
Here, usingmouse embryonic fibroblast (MEF), by combin-
ing fluorescence imaging, flow cytometry and cell fractionation
assays, we demonstrate that NH2-PS NPs cause progressive
lysosomal alterations, from earlier mild LMP to later lysosomal
expansion andmassive LMP.We also decipherwhat are the cell
death ‘signals’ coming from the ‘leaking’ lysosomes that exacer-
bate cell death. Furthermore, we describe how autophagy was
affected during the dynamic change of lysosomal status after
NP treatment.2. Results
2.1. Nanoparticles induce lysosomal alterations and
cell death
2.1.1. Nanoparticles accumulate in lysosomes and cause
lysosomal expansion and cell death
We and others have shown that most NH2-PS NPs enter cells
by endocytosis and are delivered to lysosomes in severalhuman cell lines [5,9,14,33]. We have examined the cellular
localization of NH2-PS NPs in MEF cells by confocal
fluorescence imaging. MEF cells were stained with the
lysosomotropic dye-LysoTracker Red (LTR) that selectively
accumulates in the cellular acidic compartments (mainly lyso-
somes). The confocal images in figure 1a illustrate that some
NH2-PS NPs (which fluoresce in blue channel but are coloured
in green here for better visualization) can be found to colocalize
with LTR (in red) as soon as 3 h exposure, confirming thatNH2-
PS NPs accumulate to lysosomes in MEF cells, in agreement
with what has been observed in other cell types. Strikingly,
after 6 h exposure to NH2-PS NPs, the LTR positive vesicles
significantly expand (electronic supplementary material,
figure S1), indicative of lysosomal swelling, similar to the
observations in other cell types [9,14].
To further investigate the effect ofNH2-PSNPs on lysosomal
function and cell viability, cells were co-stained with the
lysosomotropic dye-LysoTracker Green (LTG) and viability
dye-propidium iodide (PI), followed by flow cytometry
measurement. Untreated cells show positive lysosomal staining
and no rupture of the plasma membrane (LTGþ/PI2)
(figure 1b). After 3 h exposure to NH2-PS NPs, we have first
observed a reproducible increase of cells with mild or partial
LMP but still intact plasma membrane (LTG2/PI2, coloured
in cyan) (figure1b,c), similar to theonset of lysosomal-dependent
cell death reported elsewhere [20,23].
We have included the positive control t-BuOOH, a classi-
cal LMP inducer that causes lysosomal damage via oxidative
stress [20,21]. The percentage of LTG2/PI2 cell population
increases with longer exposure time and higher concentration
of t-BuOOH (electronic supplementary material, figure S2,
coloured also in cyan), supporting that the LTG2/PI2 cell
population after 3 h exposure to NPs shows LMP. Cells even-
tually become LTG2/PIþ (coloured in green; electronic
supplementary material, figure S2) after t-BuOOH treatment,
which corresponds to total rupture of lysosomes and late
stage cell death.
Intriguingly, this LTG2/PI2 population (in cyan) cannot
be observed at longer exposure time to NH2-PS NPs
(figure 1b, NP 6 h, 8 h and 24 h; figure 1c; electronic sup-
plementary material, figure S3A). Instead, the LTG intensity
of the LTGþ/PI2 (in red) population increases over time, as
is quantified in figure 1d and electronic supplementary
material, figure S3B. This result is coherent with the lysosomal
swelling phenomenon, observed with confocal fluorescence
imaging in figure 1a and previously reported data obtained
with the same particles in 1321N1 cells [14].
Similar data were obtained with a different dye combi-
nation, namely lysosomotropic dye LTR and viability dye
TO-PRO-3, to exclude the artefacts potentially caused by
interference between fluorescence dyes. The results (electronic
supplementary material, figure S4) also show a population
with LTR2/TO-PRO-3- (highlighted in the cyan box) upon
3 h exposure to NH2-PS NPs, with an increase of LTR intensity
of LTRþ/TO-PRO-3- at the later exposure time points,
confirming the above results obtained with LTG/PI staining.
We further assessed the destabilization of lysosomes
after NP treatment by ultrastructure transmission electron
microscopy (TEM) analysis. Polystyrene NPs have an electron
density very similar to cells and could be very difficult to
detect once internalized. However, careful observations and
comparison with control cells allow us to define structures that
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Figure 1. Confocal imaging and flow cytometric analysis show NH2-PS NPs induce lysosomal damage. (a) Confocal images of LTR staining. MEF cells were treated
with NH2-PS NPs (green) for 0, 3 and 6 h and stained with LTR (red). The images indicate accumulation of NPs into lysosomes at 3 h and lysosomal swelling at 6 h.
Zoomed images of cells are shown in the bottom panel. The quantification of lysosomal size is shown in electronic supplementary material, figure S1. (b) Flow
cytometric analysis of LTG/PI double staining. MEF cells were treated with NH2-PS NPs for indicated time points and stained with LTG and PI. The dot plots of PI
versus LTG are illustrated. (c) The percentage (%) of LTG2/PI2 cells in (b) at indicated time points. (d ) The MFI of LTG of LTGþ/PI2 cells in (b) at indicated time
points. Results are the mean of three experiments, each with two replicates, and the error bars are the standard deviations. (e) TEM images of 1321N1 cells treated






 on April 25, 2018http://rsob.royalsocietypublishing.org/Downloaded from in some cases abnormal morphology of ELs was also observed
after exposure to NH2-PS NPs. In addition, some NP-loaded
ELs displayed clear interruptions of their membrane, indicative
of LMP (figure 1e; electronic supplementarymaterial, figures S5
and S6, white arrows).
Together these data show dramatic and dynamic altera-
tions in lysosomal morphology after NP treatment, from
mild LMP to lysosomal swelling and destabilization.
2.1.2. Nanoparticles induce lysosomal membrane
permeabilization and cathepsin release
The characteristic sign of LMP is the release of lysosomal
content, such as cathepsins, into the cytosol [20]. Lysosomal
proteases cathepsin B and D normally reside within thelysosomal lumen, and upon LMP they can be released to cyto-
sol, leading to cell death [20,34]. To verify the mild LMP after
3 h exposure to NH2-PS NPs, we performed cell fractionation,
followed by western blot, to detect cathepsin B and D in cyto-
solic fractions of cells after exposure toNH2-PSNPs. Cathepsin
D has an unprocessed form (58 kDa) and a processed form
(27 kDa). The smaller processed form was clearly observed
in the cytosolic fraction after 3 h exposure to NPs (figure 2a),
confirming that the LTG2/PI2 population observed above
(figure 1b,c) also after 3 h exposure time to these NPs is
indeed a cell population with LMP. After 6 h exposure to
NH2-PS NPs, cathepsin B (38 kDa) can also be detected in
cytosolic fractions (figure 2a). The cytosolic levels of both cath-
epsins increase with exposure time to NH2-PS NPs, consistent


































































Figure 2. Cytosolic release of lysosomal proteases upon exposure of NH2-PS NPs and lysosomal cell death. (a) Western blot of cytosolic release of lysosomal
proteases. MEF cells were treated with NPs for indicated time points, followed by cell fractionation to obtain cytosolic and membrane fractions. Both fractions
were subjected to western blot to detect indicated proteins. LAMP1 is a lysosomal marker and GAPDH is a cytosolic marker, the results of which show no
cross-contamination of cytosolic and lysosomal fractions. Cathepsin D and B can be detected in the cytosolic fraction after 3 h and 6 h exposure to NPs, respectively.
(b) Cell death induced by NH2-PS NPs with or without lysosomal protease inhibitors. The percentages of PI positive cells were measured by flow cytometry. (c) ROS
generation upon exposure to NH2-PS NPs. MEF cells were treated with NPs as described above at indicated time points, followed by staining of 2.5 mM CM-H2DCFDA
and flow cytometric measurement. The MFI of cellular CM-H2DCFDA fluorescence is normalized by that of untreated cells at time 0. The fold changes are plotted
here. (d ) Cell death caused by NH2-PS NPs in the presence or absence of lysosomal iron chelator DFO. Results are the mean values of three experiments, each with
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figure S3.
2.1.3. NH2-PS nanoparticles induce lysosomal-dependent cell
death
Release of cathepsins from lysosomes to cytosol can lead to var-
ious apoptosis signalling [20,35–37]. We have observed that
these NPs induce early apoptosis at around 8 h in MEF cells
as AnnexinVþ/PI2 cells can be detected (electronic sup-
plementary material, figure S7). As expected, at later time
points, apoptosis proceeds to necrosis, where most of the cells
are AnnexinVþ/PIþ. This is in line with what we have pre-
viously observed in 1321N1 cells [14,15]. To continue, we
examined whether the cell death induced by NH2-PS NPs was
dependent on cathepsins by using cathepsin inhibitors. Since
we have observed the release of cathepsin B and D into cytosolupon NP treatment, we used E64d and pepstatin A (Pep A) to
inhibit their activities, respectively. Cells were exposed to
NH2-PS NPs with or without these inhibitors, and the percen-
tage of cell death was measured by flow cytometry analysis of
PI staining (figure 2b). The results show that E64d decreases
the cell death by 20% as compared with cells treated by NH2-
PS NPs alone, which may suggest a specific role for cathepsin
B in the cell death induced by these NPs. Inhibition of cathepsin
D by Pep A however does not seem to affect the extent of cell
death induced by these NPs, suggesting that either this drug
is less effective [38] or that cathepsin D plays a minor role in
propagating the damage and leading to cell death.
ROS is a well-known inducer of LMP [20,36]. Interestingly,
many NPs are known as ROS generators due to their reactive
particle surface [16,39]. However, it is essential to distinguish
this primary ROS generated at the surface of NPs from second-
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In this context,NH2-PSNPs donot have the capacity to produce
ROS directly on their surface [40]. Thus, in this case, eventual
ROS in cells is due to the damage they induce on cell structures,
such as lysosomes and mitochondria. We have previously
studied in detail whether ROS are generated before or after
the observed lysosomal alterations induced by these NPs.
With a time-resolved study, we could determine that ROS is
generated downstream as a consequence of the release of the
lysosomal content in the cytosol in 1321N1 cells [14]. Here we
examined if NH2-PS NPs induced ROS in MEF cells as well.
In line with our previous observations in 1321N1 cells, we
have observed that in MEF cells NH2-PS NPs induce a fivefold
increase of ROS measured by CM-H2DCFDA, after 3 h incu-
bation of NPs (figure 2c), thus in the same time range in
which NPs are trafficked to lysosomes. A dramatic 20-fold
increase of ROS can be observed after 8 h exposure toNPs, indi-
cating a substantial mitochondrial damage (figure 2c; electronic
supplementary material, figure S8). Indeed, TEM images show
that after 8 h NP treatment, mitochondria lost their cristae,
indicative of damage to mitochondria (electronic supplemen-
tary material, figure S9). This massive amount of ROS
probably further amplifies the damage induced by these NPs,
leading ultimately to cell death [20,36].
Oxidative damage to lysosomes can be catalysed by intraly-
sosomal low mass iron, a majority part of cellular redox-active
iron, which sensitizes lysosomal membrane and leads to event-
ual lysosomal rupture and cell death. Iron chelators, such as
desferrioxamine (DFO), have been shown to protect cells from
oxidative stress [41]. DFO enters cells via endocytosis, and
accumulates to lysosomes, where it acts as a lysosomal ROS
inhibitor by chelating lysosomal redox-active iron. Pre-incu-
bation with DFO in MEF cells significantly reduces the cell
death induced by NH2-PS NPs (figure 2d), confirming that
the generation of ROS following exposure to NH2-PS NPs is
key in the following propagation of cell damage leading to
cell death.
2.2 Nanoparticles affect autophagic pathway
2.2.1. Nanoparticles alter autophagic flux
Lysosomal alterations could directly affect autophagy [23]. We
therefore examined the generation of autophagosomes and
their fusion with lysosomes, by co-transfecting MEF cells
with LC3-RFP (red) plasmid to label autophagosomes and
lysosomal associated membrane protein 1 (LAMP1)-GFP
(green) plasmid to label lysosomes, after exposure to NH2-PS
NPs (visualized as blue). The confocal fluorescence images
show that most NH2-PS NPs colocalize with LAMP1-GFP
and the enlargement of lysosomal compartments can be
observed after 6 h exposure to NH2-PS NPs (figure 3a; elec-
tronic supplementary material, figure S10), consistent with
the results obtained by LTR staining in figure 1a. The LC3-
RFP vesicles colocalize with LAMP1-GFP in the earlier hours
(0, 3 and 6 h), suggesting that autophagosomes, at this stage,
are capable of fusing with lysosomes. However, at 12 h and
16 h, there seems to be more LC3-RFP-positive autophago-
somes (with much bigger size) that do not colocalize with
LAMP1-GFP positive lysosomes (white arrows).
To further examine autophagosomes and their fusion with
lysosomes after treatment of NH2-PS NPs, MEF cells were
transfected with RFP-GFP tandem fluorescent-tagged LC3(tf-LC3) plasmid that allows for autophagy flux assessment
[42]. After transfection, autophagosomes show yellow fluor-
escence, because LC3 is conjugated with both RFP and GFP;
when autophagosomes fuse with lysosomes to form autolyso-
somes, the GFP gets quenched in the acidic lysosomes,
therefore autolysosomes show red fluorescence [42]. In the
untreated cells, the numbers of yellow (autophagosomes)
and red (autolysosomes) punctate structures are both low
(figure 3b), which corresponds to the basal level of autophagy.
After 6 h NP treatment, more red autolysosomes can be
observed, indicative of functional autophagic flux at this
stage, which leads to the quenching of the GFP fluorescence
of tf-LC3 in autolysosomes. However, after 8 h exposure to
NH2-PS NPs, mainly yellow autophagosomes can be detected,
similar to the accumulation of yellow autophagosomes after
treatment of hydrochloroquine (HCQ) that is known to elevate
lysosomal pH and block autophagic flux [43–45]. Combining
the results of LC3-RFP/LAMP1-GFP and tf-LC3, we suspect
that a blockage of autophagy is likely after 8 h exposure to
NH2-PS NPs.
We have also performed TEM to examine the morphology
of autophagosomes and ELs. We have observed a massive
accumulation of double and multiple membrane structures,
namely autophagosomes (APs) and multivesicular bodies
(MVBs) [46], in the cells treated by NH2-PS NPs for 8 h
(figure 3c; electronic supplementary material, figure S11A).
Moreover, we have observed that vesicles containing NH2-PS
NPs (probably endosomes or lysosomes) are surrounded by
double membrane structures (black arrows in figure 3c, left
panel; electronic supplementary material, figure S11A),
suggesting that they could be amphisomes (formed by fusion
between autophagosomes and endosomes) or autolysosomes.
Finally, we have evaluated the autophagic flux through
western blot detection of LC3-II in the presence or absence of
lysosomal inhibitors and the levels of the autophagy substrate
p62. We have observed that NP treatment can increase the
levels of LC3-II after 8 h exposure to NH2-PS NPs (figure 4a;
electronic supplementary material, figure S11B), confirming
the accumulation of autophagosome after 8 h NP treatment.
The accumulation of LC3-II can be either induction or blockage
of autophagic flux [29]. To assess the autophagic flux, we have
compared the difference of LC3-II levels after NP treatment
with orwithout lysosomal inhibitor HCQ over time. The result-
ing plot indicates that autophagic flux is slightly induced after
3–6 h treatment of NH2-PS NPs; however, after 8 and 24 h
exposure to NH2-PS NPs, there is a decrease of autophagic
flux (figure 4b). This correlates with the western blot detection
of p62 (figure 4a), a substrate which is degraded by autophagy
[47]. We have first observed a decrease of p62 in the first 6 h of
NP treatment (indicative of induced autophagic flux), followed
by an increase of its amount after 8 and 24 h (reflecting the
blockage of autophagic flux). Together with the fluorescence
images shown above (figure 3a,b), our data strongly indicate
that in the first 6 h exposure to NPs, autophagy is functional,
while after 8 h NPs induce blockage of autophagic flux, prob-
ably due to the fact that lysosomes are severely damaged at
this time.
2.2.2. Nanoparticles interact with PI3 K/AKT/mTOR signalling
pathway
Thephosphatidylinositol-3-kinase (PI3 K)/AKT/mTOR (mam-





















Figure 3. NH2-PS NPs induce accumulation of autophagosomes. (a) Confocal images of autophagosomes and lysosomes after NP treatment. MEF cells were co-
transfected with LC3-RFP (red) and LAMP-1 (green), and exposed to NH2-PS (blue) for indicated time points. White arrows indicate the autophagosomes that do not
colocalize with lysosomes. The scale bar is 10 mm. (b) Confocal images of MEF cells transfected with tf-LC3 plasmid followed by exposure to NH2-PS NPs for
indicated times or HCQ. (c) TEM images of autophagic vesicles. AP, autophagosome; EL, endolysosome. Black arrows indicate the double membrane structures





 on April 25, 2018http://rsob.royalsocietypublishing.org/Downloaded from regulate autophagy in response to nutritional status and other
stimuli [48]. PI3 K activated by pro-surviving signals could in
turn activate and phosphorylate AKT. Activated AKT signals
to mTOR, which activates and phosphorylates its downstream
effector p70S6 kinase (S6 K). This pathway negatively regulates
autophagy [49]. Therefore, the amount of phosphorylated ATK
and S6 K (pATK and pS6 K) negatively correlate with autop-
hagy activation. After exposure to NH2-PS NPs, we have
observed a decrease of pAKTat 8 h andpS6 K at 24 h (electronic
supplementarymaterial, figure S11C), indicative of inhibition of
mTOR and activation of autophagy. This is consistent with the
induction of autophagy observed above. Similar activation of
autophagy through PI3 K/AKT/mTOR signalling pathway
after exposure to NH2-PS NPs has been observed in RAW264.7 and BEAS-2B cells [50]. In conclusion, NH2-PS NPs
regulate mTOR-dependent autophagy.
2.2.3. Inhibition of autophagy sensitizes cells to
nanoparticle treatment
The role of autophagy can be different in different cell death
scenarios. Inmany cases, autophagy serves as a survivalmech-
anism to cope with the cellular stress; however, in other cases,
cells also die with autophagic features [51,52]. Here, we exam-
ine the role of cell death with pharmacological inhibitors of
autophagy, including both 3-methyladenine (3-MA) and wort-
mannin.WhenMEF cells were treatedwith NH2-PS NPs in the
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Figure 4. Treatment of NH2-PS NPs blocks autophagic flux. (a) Western blot of autophagy markers in MEF cells treated with NPs with or without HCQ. The LC3-II
levels were plotted in electronic supplementary material, figure S11B. Higher exposure time for the revelation of LC3 western blot is shown in electronic supplemen-
tary material, figure S11C. (b) Analysis of autophagic flux. The autophagic flux was calculated as ratios via dividing the levels of LC3-II after NP treatment in the
presence of HCQ by that in the absence of HCQ. Results are mean values from two independent experiments, and the error bars are standard deviations. (c) Cell
death induced by NH2-PS NPs in the presence of pharmacological modulators of autophagy. MEF cells were treated by NH2-PS NPs for 24 h with or without
autophagy inhibitors (3-MA or wortmannin) or an autophagy inducer (rapamycin). The percentages of PI positive cells were plotted. Results of the effects of
the inhibitors on 8 h treatment with NPs are shown in electronic supplementary material, figure S12. Results are mean values from three independent experiments





 on April 25, 2018http://rsob.royalsocietypublishing.org/Downloaded from level of cell death (figure 4c; electronic supplementarymaterial,
figure S12), indicating that autophagy is a pro-survival mech-
anism in the cell death induced by NH2-PS NPs. This result
also supports the results of inhibition of mTOR after 8 h
(§2.2.2) that autophagy is indeed activated in order to deal
with the damage induced by NPs. Interestingly, autophagy
induction with rapamycin augmented cell death (figure 4c;
electronic supplementary material, figure S12), suggesting
that increasing autophagosome formation under conditions
of lysosomal dysfunction is detrimental for cell survival. In
all, lysosomes are no longer functional after NP treatment
and autophagy fails to save the cells from the NP-induced
stress, leading to accumulation of autophagosomes and
eventual cell death [23,42].
2.2.4. Impact of nanoparticles on autophagy in 1321N1 cells
We have previously demonstrated that in 1321N1 cells, NH2-PS
NPs induce accumulation of autophagosomes by both western
blot and confocal fluorescent imaging of LC3-II [14]. Here, we
have complemented this study by examining autophagosomes
via TEM, assessing autophagic flux and monitoring PI3 K/ATK/mTOR signalling pathway in parallel with the above
studies in MEF cells. First, TEM (electronic supplementary
material, figure S13A) results show that double and multiple
membrane structures can be found after NP treatment in
1321N1 cells, confirming the accumulation of autophagosomes.
Thenwe have analysed the autophagic flux in 1321N1 cells after
exposure toNH2-PSNPs. The analysis of LC3-II levels uponNP
exposure with or without HCQ suggests that the autophagic
flux is decreased after NH2-PS NPs treatment even after 1 h
exposure to NH2-PS NPs (electronic supplementary material,
figure S13b,c), indicating that the accumulation of LC3-II is
due to blockage of autophagy after NP treatment. We have
also tested E64d as a lysosomal inhibitor, andwe have observed
no increase of LC3-II in the presence of E64d upon exposure to
NH2-PS NPs compared with that of NP treatment alone (elec-
tronic supplementary material, figure S13D), supporting that
autophagic flux was indeed blocked upon NP treatment. p62
level was also assessed, and we have observed only a small
decrease of p62 after 1 h treatment, and the amount increases
after 3 h NP treatment (figure 13B), confirming the blockage
of autophagy after exposure to NH2-PS NPs at this exposure
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Figure 5. Scheme of LMP and deregulated autophagy induced by NH2-PS NPs. NH2-PS NPs are endocytosed into lysosomes. After 3 h, these NPs cause mild LMP,
leading to leakage of small lysosomal components (processed cathepsin D, 27 kDa) into cytosol. Gradually, after 6 h, the LMP is exacerbated, marked by the release
of larger lysosomal components (cathepsin B, 38 kDa). Lysosomal expansion due to the ‘proton sponge’ effect of these cationic NPs can be also observed. At this
point, the NP-loaded lysosomes might still be functional, and autophagosomes generated from basal level autophagy can still be fused and degraded. However,
after 8 h exposure to NPs, lysosomal expansion and LMP continue to aggravate. The released cathepsins can directly lead to caspase-independent cell death
(process a), or perturb mitochondria (process b), resulting into ROS generation and apoptotic cell death (process c). The generated ROS can lead to more
severe LMP, serving as a feedback loop (process d ). Autophagy is induced, likely due to the damaged mitochondria and ROS (process e). However, the generated





 on April 25, 2018http://rsob.royalsocietypublishing.org/Downloaded from 6 h exposure to NH2-PS NPs. All these results suggest that in
both MEF and 1321N1 cells, autophagy could be activated
upon NP exposure; however, the final consequence is the over-
all blockage of autophagic flux, due to the severe damage to
lysosomes.3. Discussion
3.1. The time profile of lysosome and autophagy
alternations induced by nanoparticles
We summarize the progression of alternations of lysosomes and
autophagy induced by NH2-PS NPs in MEF cells in figure 5.
NPs accumulate to lysosomes as early as 3 h after exposure
and they lead to mild LMP, detected by loss of LysoTracker
staining (figure 1b,c) and release of cleaved cathepsin D
(27 kDa), a relatively small component from lysosomes, into
the cytosol (figure 2a). After 6 h of incubation with NPs, lyso-
somes have been found to be dramatically expanded,
illustrated by increased intensity of LysoTracker (figure 1a,b,d)
and enlarged lysosomes (electronic supplementary material,
figure S1). At the same time, a larger lysosomal component,
cathespin B (38 kDa), can be found in the cytosol, reflecting a
larger extent of LMP than that after 3 h exposure time to NPs.
At this stage, autophagy is still functional and autophagosomes
can fuse with lysosomes for degradation (figures 3a,b and 4b).
Eight hours seems to be a critical point after NP treatment,
when many signalling events occur. The lysosomal volume is
increased even more (figure 1b,d), accompanied by even more
severe LMP (figure 2a). The released cathepsins could cleave
cytosolic proteins and lead to caspase-independent cell death
(figure 5, process a), and at the same time they can also perturbmitochondria, resulting into ROS generation that further
propagates the cell damage (figure 5, process b) [20,36,37,53].
Mitochondrial outer membrane permeabilization is marked
as the ‘point-of-no-return’ for cell death (figure 5, process c).
The massive ROS generated by damaged mitochondria could
in turn further damage lysosomal membranes, forming a
‘feedback’ loop (figure 5, process d) [54]. The damaged mito-
chondria and ROS could induce autophagy to remove the
damaged mitochondria (figure 5, process e) [55]. However,
because the lysosomes are not functional any more, the
generated autophagosomes are no longer able to fusewith lyso-
some and get degraded (figure 5, process f), which aggravates
NP-induced cell death.
3.2. The lysosomal membrane permeabilization induced
by NH2-PS nanoparticles is progressive
In this study, using two distinct methods, we provide a very
refined illustration of LMP induced by NH2-PS NPs in MEF
cells, where mild LMP can be detected as early as after 3 h
exposure to these NPs, probably in a small population of
MEF cells that are more sensitive to NPs. The mild LMP
can be detected by the loss of LysoTracker dyes already at
3 h exposure to these NPs (figure 1b,c), preceding cell
death, as those cells are still negative to the viability dye PI.
It correlates well also with the detection of cleaved cathepsin
D (27 kDa), a relatively small component from lysosomes, in
the cytosol at 3 h (figure 2a). After 6 h exposure, cathepsin B,
with higher molecular weight (38 kDa), can be detected in the
cytosol as well. This strongly supports that the LMP induced
by these NPs is mild and partial at the earlier exposure times
to NPs and progressively aggravates with time. This size-
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ated LMP, while larger dextran molecules were retained [56].
This early LMP at 3 h is likely to be upstream of all other
apoptotic events, as a small percentage of cells are detected
as Annexin Vþ/PI2 only at 8 h exposure to NPs.
Our data support that detecting lysosomal content in the
cytosol is probably the best way to analyse LMP, as LMP
cannot be followed only by flow cytometric analysis of LTG
and PI in the later time points (after 6 h). Two hypotheses
could be given to explain the disappearance of LTG2/PI2
population, which is supposed to represent the cells with
LMP, in the later time points. First, we suspect that the
global dramatic increase of LTG intensity masks the small
decrease of LTG in the cells with mild LMP. Second, these
might be the most sensitive cells, which die directly after a
few hours of exposure to these NPs. Overall, caution needs
to be taken when interpreting flow cytometry results using
LysoTracker dyes, because an increase in its intensity (as an
example) could be due to an increase in lysosomal volume,
lysosomal numbers or their acidity. Other techniques are
needed to be able to discriminate these different options.
Finally, NH2-PS NPs can cause LMP through three differ-
ent mechanisms. First, the positive charge of these NPs could
damage lysosomal membrane, because they accumulate
inside lysosomes and positive charges are known to
damage biological membranes [57,58]. Second, lysosomal
enlargement induced by these NPs can sensitize lysosomes
to LMP, as larger lysosomes are proposed to be more suscep-
tible to rupture [59]. Third, ROS could be an important factor
in LMP as lysosomes are highly sensitive to ROS [35].
Increase of ROS has been observed after 3 h exposure to
NPs, the same time when NPs have been found accumulating
to lysosomes. After 8 h exposure, there is a dramatic increase
of ROS, which we think might be related to the extensive
LMP, leading to release of lysosomal proteases (cathepsin B
and D) which damage mitochondria. Damaged mitochondria
could lead to release of ROS, amplifying the ROS level and
cell death signalling as discussed above. Our previous data
suggest that damage to mitochondria is a downstream pro-
cess after LMP induced by these NPs. In 1321N1 cells,
lysosomal protease inhibitors (pepstatin A and E64d) could
retard not only cell death, but also decrease the levels of
ROS and caspase 3/7 [14].
We have also observed that the ROS-induced cell death
could be partially inhibited by iron chelator DFO. The involve-
ment of iron in the cell death induced by these NPs could be
related to ferroptosis, a recently discovered form of regulated
cell death [60]. Ferroptosis is characterized by lipid peroxi-
dation dependent on ROS generation and iron availability
[61], the involvement of which in the toxicity induced by
cationic NPs still needs to be explored.
Lysosomal enlargement after treatment of NH2-PS NPs
could be due to the ‘proton sponge effect’ of these protonatable
NPs [16,18]. However, we and others have observed that posi-
tive NPs that are unprotonatable could also result in lysosomal
swelling [9,18], suggesting that other damages to lysosomal
membrane structures (proton pumps, chloride proton exchan-
gers, etc.) could lead to increase of lysosomal volume [19].
Another possible explanation for lysosomal swelling is based
on the recent findings on the activation of transcription factor
EB (TFEB), a master regulator of lysosomal biogenesis, upon
exposure to NH2-PS NPs in Hela and PC12 cells [62]. TFEB is
probably upregulated as a feedbackmechanism to compensatethe dysfunctional lysosomes, aswas observed in lysosomal sto-
rage diseases [63]. However, this possibility remains to be
studied in MEF cells after NP treatment.
3.2. Autophagy is induced at the upstream but suppressed at the
downstream
Autophagy is a multistep process, including the formation of
autophagosomes, fusion between autophagosomes and lyso-
somes, and degradation of autophagosomes by lysosomes
[28]. Our data strongly suggest that NH2-PS NPs induce
upstream autophagosome formation. However, because lyso-
somes suffer strong damage due to accumulation of NH2-PS
NPs, the downstream steps of autophagy, namely fusion
between autophagosomes and lysosomes and/or degra-
dation of autophagosomes, are compromised, leading to an
overall decrease of the autophagic flux.
Our results show that mTOR-dependent autophagy is acti-
vated after 8 h, reflected by the inhibition of pATK at this time
(electronic supplementary material, figure S11C). This acti-
vation of autophagy might be due to various factors related
to the observed lysosomal alterations, as a surviving mechan-
ism to help the cell to adapt from the NP-induced stress
(figure 4c). First, ROS could directly activate autophagy
[55,64]. We have observed a dramatic increase of ROS after
8 h incubation with NPs, the same time when we have
observed the inhibition of mTOR and activation of autophagy.
Second, we speculate that the released cathepsins could cause
damage in mitochondria, which could cue autophagy to
remove them through mitophagy, a type of selective auto-
phagy [65]. Third, lysophagy, another type of selective
autophagy, could be activated in order to remove the damaged
lysosomes [66]. Lastly, the activation of autophagy might be
related to the possible upregulation of TFEB as mentioned
above. Activation of TFEB could induce lysosomal expansion
as well as activation of autophagy [67].
Despite the activation of autophagy as a cell surviving
mechanism, the permeabilized lysosomes are no longer func-
tional at the later time points. Therefore, the generated
autophagosomes cannot be degraded by lysosome, leading
to blockage of autophagic flux. Similar results showing induc-
tion of autophagy and reduced autophagic flux have been
obtained in some other cell lines after exposure to NH2-PS
NPs [37,52], and in L-02 and HepG2 cells after treatment of
100 nm silica NPs [68].
It is worth mentioning again that analysing autophagy in
a time course allows us to monitor not only the activation/
blockage of autophagy at difference stages, but also the rate
of autophagic flux over time. At the same time, the time
profile allows us to correlate the progression of lysosomal
damage with that of autophagy activities. Furthermore, it is
strongly argued nowadays that a combination of techniques
(such as TEM, fluorescence imaging of autophagy reporters,
western blot of markers for autophagy and PI3 K/ATK/
mTOR pathway, as were used in this study) needs to be
used to in order to follow the highly dynamic process of
autophagy [69].4. Conclusion
Wedemonstrated that NH2-PSNPs accumulate to lysosomes in





 on April 25, 2018http://rsob.royalsocietypublishing.org/Downloaded from LMP in a progressive manner, accompanied by release of cath-
epsins into cytosol and generation of ROS. In a small fraction of
cells, mild LMP appears at earlier times without evident lyso-
some expansion. Autophagy is activated as a surviving
mechanism to deal with the NP-induced stress. However,
because lysosomes are extensively damaged upon NP
treatment, the clearance of generated autophagosomes via
lysosomes is greatly compromised and the autophagic flux
is decreased. Our data provide new evidence and detailed
mechanisms of lysosome and autophagy alternations induced
by cationic NPs. Furthermore, our data suggest that it is of
great importance to examine the impact of NPs on lysosomes
in the context of nanotoxicity, because most NPs accumulate
in this compartment, and once there, digestion of their
protein corona has been observed. This is also important for
drug delivery when lysosome-related pathways (such as
autophagy) are the designed target for NPs, as the impact
of NPs on lysosomes could dramatically change the course of
lysosomal-dependent pathways.5. Material and methods
5.1. Cell culture and nanoparticles
The MEF cells were kindly provided by Noboru Mizushima
(Tokyo Dental and Medical University, Tokyo, Japan), and
1321N1 cells were obtained from the European Collection of
Cell Cultures (ECACC). Cells were routinely cultured in
Dulbecco’s Modified Eagle’s Medium Glutamax (DMEM)
(Life Technologies) supplemented with 1% glutamine, 10%
heat-inactivated fetal bovine serum (Life Technologies) and
50 units ml21 of penicillin and 50 mg ml21 of streptomycin
in a 378C incubator with 95% air/5% CO2 atmosphere. Cells
were grown to 70–80% confluency before treatment. Fifty
nanometres of blue fluorescently labelled NH2-PS NPs was
purchased from Sigma-Aldrich and their characterizations
can be found in [9,15]. NH2-PS NPs were used at 50 mg ml
21
for all studies, as has been optimized previously for studies
of cell death [9,14,15,33].
5.2. Confocal fluorescence microscopy
To examine the colocalization of NPs and lysosomes,MEF cells
were treated with NH2-PS NPs for indicated time points, fol-
lowed by staining of 1 mM LTR (Life Technologies) in DMEM
for 30 min at 378C. Stained cells were washed with PBS and
fixed with 4% paraformaldehyde (PFA) at room temperature
for 30 min, followed by permeabilization with 0.1% SDS at
room temperature for 1 h and image acquisition.
To monitor the cellular location of autophagosomes
in respect to lysosomes after NP treatment, MEF cells were
transfected either with GFP-LAMP1 (kindly provided by
J. Lippincott-Schwartz), and RFP-LC3 plasmids together, or
with tf-LC3 (both provided by T. Yoshimori), using Lipofecta-
mine 2000 (Life Technologies) according to manufactures’
instruction. The transfected MEF cells were exposure to
50 mg ml21 NH2-PS NPs for indicated time points. Cells were
subjected to imaging immediately without fixation.
All imaging acquisition was carried out with a Leica TCS
SP5 confocal laser scanning microscope equipped with
405 nm, 488 nm and 562 nm lasers to excite NPs, GFP and
RFP (or LTR), respectively.5.3. Flow cytometry measurement
After exposure to NPs for indicated time points or to positive
control t-BuOOH for indicated concentrations and time
points, cells were harvested by trypsin and stained with
100 nM LTG (Life Technologies) for 15 min at 378C and
20 mg ml21 PI (Sigma) for 3 min at room temperature. After
staining, the cell fluorescence was immediately measured
with a Cyan ADP flow cytometer (Beckman Coulter), using a
488 nm laser to excite both fluorophores, FL1 (520+20 nm)
band pass filter to collect LTG fluorescence and FL2 (613+
20 nm) band pass filter to collect PI fluorescence. The data
analysis was carried out using SUMMIT software (DAKO).
Gates were set to discriminate cell debris and cell doublets
according to the forward and side scattering. The dot plots of
PI versus LTGwere compensatedwith proper controls. A quad-
rat gate in these dot plots was set according to the 0 h untreated
cells and used throughout the analysis. The four populations
were coloured accordingly to facilitate visualization. Results
are representative of three independent experiments, each
performedwith two replicates. Alternatively, cells were stained
with 100 nM LTR and 1 mM TO-PRO 3 and analysed in
the same way. The results are presented in the electronic
supplementary material.
5.4. Cellular fractionation and western blot
The MEF cells were firstly exposed to NPs for indicated
times. Separation of cytosolic fractions (lysosome-free) and
membrane fractions (containing lysosomes and mitochon-
dria) of MEF cells after treatment of NH2-PS NPs was
performed as previously described [37]. Twenty micrograms
of protein extract was resolved by 12% SDS-PAGE and trans-
ferred onto polyvinylidene difluoride (PVDF) membranes.
The membranes were blocked for 1 h in PBS-Tween-20
(0.05% (v/v)) containing 5% non-fat milk and probed with
primary antibodies against cathepsin B and D (Abcam,
Cambridge, MA, USA), followed by incubation with corre-
sponding horseradish peroxidise conjugated secondary
antibodies (Sigma). LAMP-1 (Sigma) was used as a control
to show no contamination of lysosomes in cytosolic
fractions; glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (Cell Signalling) was an endogenous control to
show equally loading.
For the other western blot experiments, cells were treated
with NPs for indicated time points and cellular proteins were
extracted with home-made lysis buffer (50 mM Tris–HCl pH
6.8, glycerol 10% (v/v), 2% SDS (w/v), 10 mM DTT and
0.005% bromophenol blue) and subjected to western blot as
previously described [23]. LC3 antibody was purchased from
Sigma. Antibodies against p62, pAKT, pS6 were purchased
from Cell Signaling (Danvers, MA, USA), and GAPDH from
Abcam. Densitometry was performed using IMAGEJ software
(Nationcal Institute of Health).
5.5. Treatment of pharmacological compounds and cell
death assay
In figure 2b, MEF cells were pre-treated with 50 mM pepstatin
A (Pep A) or/and 30 mM E64d (Sigma-Aldrich) for 16 h
before exposure to NPs. In figure 2d, MEF cells were pre-
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3-MA (Sigma-Aldrich), 5 mM wortmannin (Calbiochem) or
200 nM rapamycin (Sigma-Aldrich) for 1 h before NP treat-
ment. All inhibitors were present when cells were exposure
to NPs for 16 h, except that DFO was removed before NP
treatment. Cells were stained with 20 mg ml21 PI for 3 min
before measurement with flow cytometry; 15 000 cells were
recorded in each analysis in an EPICS XL flow cytometer
(Beckman Coulter, Barcelona, Spain). The percentage of cell
death was determined by the percentage of PI positive cells
with flow cytometry. The values are the average of two
replicates from three individual experiments.
5.6. Transmission electron microscopy
The MEF cells treated with NPs for 8 h or untreated were
fixed with 3% glutaraldehide and postfixed with 1%
osmium and 1.5% potassium ferricyanid. The samples were
dehydrated in an ethanol series and embedded in LX 112
resin (Fisher Scientific). Ultra-thin sections of 60 nm were
cut and stained with 2% uranyl acetate and lead citrate.
Samples were subjected to imaging with a JEOL transmission
electron microscope (80 kV) equipped with TemCam-F416
TVIPS camera.Data accessibility. The datasets supporting this article are detailed in the
electronic supplementary material.
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